Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitorsY M Rustum, A Harstrick, S Cao, et al.European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinomaD Strumberg, J Erhard, A Harstrick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancerU Vanhoefer, A Harstrick, C H Köhne, et al.Anti-Cancer Drugs|October 1, 1995
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell linesA Harstrick, U Vanhoefer, N Schleucher, et al.Oncology Research|January 1, 1997
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cellsU Vanhoefer, W Voigt, R A Hilger, et al.Anti-Cancer Drugs|March 1, 1997
Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracilD Strumberg, A Harstrick, U Klaassen, et al.Cancer Chemotherapy and Pharmacology|July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumorsR A Hilger, A Harstrick, W Eberhardt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancerU Vanhoefer, H Wilke, H J Weh, et al.Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.Oncology (Williston Park, N.Y.)|April 1, 1997
Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancerU Klaassen, H Wilke, C Müller, et al.Pageof 9